Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
76
ADMA Quote, Financials, Valuation and Earnings
Last price:
$18.72
Seasonality move
:
12.98%
Day range:
$18.36 - $19.21
52-week range:
$5.88 - $23.64
Dividend yield:
0%
P/E ratio:
22.77x
P/S ratio:
10.61x
P/B ratio:
12.66x
Volume:
3.7M
Avg. volume:
2.6M
1-year change:
211.69%
Market cap:
$4.4B
Revenue:
$426.5M
EPS (TTM):
$0.82
Earnings Data
Next earnings date for ADMA
May 09
2025
Most recent earnings per share
$0.46
Beat by $0.31
(Mar 3/2025)
Consensus Estimate
$0.15
(Mar 3/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ADMA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/09/2025 | Q1 | $115.5M | -- | -- | $0.14 | -- |
| 03/03/2025 | Q4 | $112.8M | $117.5M | $0.46 | $0.15 | $0.31 |
| 11/07/2024 | Q3 | $105.9M | $119.8M | $0.15 | $0.13 | $0.02 |
| 08/08/2024 | Q2 | $86.4M | $107.2M | $0.13 | $0.08 | $0.05 |
| 05/09/2024 | Q1 | $77.3M | $81.9M | $0.08 | $0.05 | $0.03 |
| 02/28/2024 | Q4 | $73M | $73.9M | -$0.08 | $0.02 | -$0.10 |
| 11/08/2023 | Q3 | -- | -- | $0.01 | -$0.01 | $0.02 |
| 08/09/2023 | Q2 | -- | -- | -$0.03 | -$0.03 | -$0.00 |
| 05/10/2023 | Q1 | -- | -- | -$0.03 | -$0.04 | $0.01 |
| 03/23/2023 | Q4 | -- | -- | -$0.06 | -$0.07 | $0.01 |
| 11/09/2022 | Q3 | -- | -- | -$0.08 | -$0.07 | -$0.01 |
| 08/10/2022 | Q2 | -- | -- | -$0.07 | -$0.08 | $0.01 |
| 05/11/2022 | Q1 | -- | -- | -$0.13 | -$0.08 | -$0.05 |
| 03/24/2022 | Q4 | -- | -- | -$0.09 | -$0.09 | $0.00 |
| 11/10/2021 | Q3 | -- | -- | -$0.13 | -$0.14 | $0.01 |
| 08/11/2021 | Q2 | -- | -- | -$0.15 | -$0.16 | $0.01 |
| 05/12/2021 | Q1 | -- | -- | -$0.16 | -$0.17 | $0.01 |
| 03/25/2021 | Q4 | -- | -- | -$0.20 | -- | -- |
| 11/05/2020 | Q3 | -- | -- | -$0.19 | -- | -- |
| 08/05/2020 | Q2 | -- | -- | -$0.23 | -- | -- |
| 05/06/2020 | Q1 | -- | -- | -$0.26 | -- | -- |
| 03/12/2020 | Q4 | -- | -- | -$0.18 | -- | -- |
| 11/06/2019 | Q3 | -- | -- | -$0.19 | -- | -- |
| 08/08/2019 | Q2 | -- | -- | -$0.25 | -- | -- |
| 05/08/2019 | Q1 | -- | -- | -$0.28 | -- | -- |
| 03/13/2019 | Q4 | -- | -- | -$0.39 | -- | -- |
| 11/08/2018 | Q3 | -- | -- | -$0.33 | -- | -- |
| 08/10/2018 | Q2 | -- | -- | -$0.35 | -- | -- |
| 05/14/2018 | Q1 | -- | -- | -$0.39 | -- | -- |
| 03/05/2018 | Q4 | -- | -- | -$0.29 | -- | -- |
| 11/03/2017 | Q3 | -- | -- | -$0.59 | -- | -- |
| 08/11/2017 | Q2 | -- | -- | -$0.55 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.51 | -- | -- |
| 02/24/2017 | Q4 | -- | -- | -$0.35 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.34 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$0.50 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$0.43 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$0.45 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$0.48 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$0.44 | -- | -- |
| 03/31/2015 | Q1 | -- | -- | -$0.37 | -- | -- |
ADMA Biologics Earnings Questions
-
How Much did ADMA Biologics Generate in Revenue Last Quarter?
ADMA Biologics reported $117.5M worth of top line sales in its most recent quarter.
-
Did ADMA Biologics Beat Earnings Last Quarter?
ADMA Biologics announced earnings per share of $0.46 which represents a beat of analyst forecast a $0.15 per share.
-
Is ADMA Biologics Profitable?
ADMA Biologics reported $63.3M that represents $0.26 per share over the last quarter.
-
What is the Analyst Consensus for ADMA Biologics EPS Next Year?
ADMA Biologics's earnings are forecast to decrease from $0.81 per share to $0.52 per share next year representing a decrease of -12.96%.
-
When is ADMA Biologics's Earnings Date?
ADMA Biologics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
